Financials
Income statement
Fiscal date | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
---|---|---|---|---|
Total reported revenue | 1.7B | 1.7B | 1.7B | 1.7B |
Cost of revenue | 850M | 802M | 782M | 785M |
Gross profit | 888M | 866M | 899M | 916M |
Operating expense | ||||
Research & development | 111M | 112M | 113M | 111M |
Selling general and admin | 417M | 454M | 410M | 397M |
Other operating expenses | — | — | — | — |
Operating income | 360M | 300M | 376M | 408M |
Non operating interest income | ||||
Income | 16M | 14M | 15M | 24M |
Expense | 28M | 29M | 28M | 32M |
Other income expense | 18M | -25M | 4M | 1M |
Pretax income | 366M | 260M | 367M | 401M |
Tax provision | 30M | 45M | 49M | 50M |
Net income | 336M | 215M | 318M | 351M |
Basic EPS | 1.2 | 0.8 | 1.1 | 1.2 |
Diluted EPS | 1.2 | 0.8 | 1.1 | 1.2 |
Basic average shares | 284M | 285M | 285M | 286M |
Diluted average shares | 285M | 285M | 287M | 287M |
EBITDA | 466M | 362M | 467M | 502M |
Net income from continuing op. | 336M | 215M | 318M | 351M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |